01:21:32 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-17 Kvartalsrapport 2024-Q3
2024-07-12 Kvartalsrapport 2024-Q2
2024-04-19 Ordinarie utdelning ARJO B 0.90 SEK
2024-04-18 Kvartalsrapport 2024-Q1
2024-04-18 Årsstämma 2024
2024-01-30 Bokslutskommuniké 2023
2023-10-19 Kvartalsrapport 2023-Q3
2023-07-13 Kvartalsrapport 2023-Q2
2023-07-12 Kvartalsrapport 2023-Q2
2023-04-21 Ordinarie utdelning ARJO B 0.85 SEK
2023-04-20 Kvartalsrapport 2023-Q1
2023-04-20 Årsstämma 2023
2023-01-25 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-14 Kvartalsrapport 2022-Q2
2022-04-25 Ordinarie utdelning ARJO B 1.15 SEK
2022-04-22 Kvartalsrapport 2022-Q1
2022-04-22 Årsstämma 2022
2022-02-03 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-04-28 Ordinarie utdelning ARJO B 0.85 SEK
2021-04-27 Kvartalsrapport 2021-Q1
2021-04-27 Årsstämma 2021
2021-02-03 Bokslutskommuniké 2020
2020-10-28 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-06-30 Ordinarie utdelning ARJO B 0.65 SEK
2020-06-29 Årsstämma 2020
2020-04-27 Kvartalsrapport 2020-Q1
2020-02-04 Bokslutskommuniké 2019
2019-10-22 Kvartalsrapport 2019-Q3
2019-07-18 Kvartalsrapport 2019-Q2
2019-05-08 Ordinarie utdelning ARJO B 0.55 SEK
2019-05-07 Årsstämma 2019
2019-05-07 Kvartalsrapport 2019-Q1
2019-02-04 Bokslutskommuniké 2018
2018-10-22 Kvartalsrapport 2018-Q3
2018-07-19 Kvartalsrapport 2018-Q2
2018-05-07 Ordinarie utdelning ARJO B 0.50 SEK
2018-05-04 Kvartalsrapport 2018-Q1
2018-05-04 Årsstämma 2018
2018-01-29 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Arjo är ett globalt bolag med verksamhet inom sjukvårdsindustrin. Bolaget är idag specialiserade inom utvecklingen av medicintekniska produkter. Produktportföljen är bred och inkluderar exempelvis sjukvårdssängar, golv- och taklyftar, desinfektionslösningar, samt av hygienprodukter och kompressionslösningar. Utöver erbjuds service och tillhörande tjänster samt utbildning. Störst verksamhet återfinns inom Europa och Nordamerika.
2022-04-22 13:45:00

Arjo AB (publ) held the 2022 Annual General Meeting on Friday 22 April. At the Annual General Meeting the following was resolved:

Adoption of the Income Statement and the Balance Sheet
The Annual General Meeting adopted the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet for the financial year 2021.

Dividend
In accordance with the proposal of the Board of Directors and the CEO, the Annual General Meeting resolved to declare a dividend of SEK 1.15 per share. 26 April 2022 was determined as record date for dividend.

Discharge from liability
The Board members and the CEO were discharged from liability for their administration of the company for the financial year 2021.

Election of Board of Directors
Johan Malmquist (Chairman), Carl Bennet, Eva Elmstedt, Dan Frohm, Ulf Grunander, CarolaLemne and Joacim Lindoff were re-elected as members of the Board.

Fees to the Board of Directors
It was resolved that remuneration to the Board of Directors shall amount to a total of SEK4,775,000 excluding remuneration for Committee work, of which SEK1,525,000 to the Chairman and SEK650,000 to each of the other Board members elected by the Meeting who are not employees of Arjo Group. In addition hereto, the Meeting resolved that work in the Audit Committee shall be compensated with SEK270,000 to the Chairman and SEK135,000 to each of the other members, while work in the Remuneration Committee shall be compensated with SEK145,000 to the Chairman and SEK103,000 to each of the other members.

Election of auditors
The registered public accounting firm Öhrlings PricewaterhouseCoopers AB was re-elected auditor of the company for a term of one year. The public accounting firm has informed that Cecilia Andrén Dorselius will be the auditor in charge. It was resolved that auditor fees shall be paid in accordance with approved account.

Guidelines for Remuneration to Senior Executives
The Annual General Meeting resolved to approve the Guidelines for Remuneration to Senior Executives as proposed by the Board of Directors.

Remuneration report
The Annual General Meeting resolved to approve the Board of Directors' report over remuneration in accordance with Chapter 8 section 53 a, the Swedish Companies Act, regarding the financial year 2021.

For more information, please contact:

Maria Nilsson, TF EVP Marketing Communication & Public Relations

Tel: +46 734 244 515

Email:maria.nilsson@arjo.com

Sara Ehinger, VP Investor Relations & Corporate Communications

Tel: +46 723 597 794

Email:sara.ehinger@arjo.com

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With 6,500 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com